Evidence map›Paper›PMID 25437001›Full record

ArticlePloS one2014

Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.

Daniel L Coutu, Wally Mahfouz, Oleg Loutochin, Jacques Galipeau, Jacques Corcos

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. [Advance in functional bladder engineering].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Bioengineering Approaches for Bladder Regeneration.International journal of molecular sciences · 2018
    Review
  14. Review
  15. Review
  16. Article
  17. Stem Cells in Functional Bladder Engineering.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2016
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Daniel L CoutuDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Wally MahfouzDepartment of Urology, Jewish General Hospital, McGill University, Montreal, Canada; Department of Urology, Alexandria University, Alexandria, Egypt.
Oleg LoutochinDepartment of Urology, Jewish General Hospital, McGill University, Montreal, Canada.
Jacques GalipeauDepartment of Hematology and Medical Oncology, Pediatrics & Medicine, Emory University, Atlanta, Georgia, United States of America.
Jacques CorcosDepartment of Urology, Jewish General Hospital, McGill University, Montreal, Canada.
McGill University · CAAlexandria University · EGEmory University · USETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder replacement or augmentation is required in congenital malformations or following trauma or cancer. The current surgical solution involves enterocystoplasty but is associated with high complication rates. Strategies for bladder tissue engineering are thus actively sought to address this unmet clinical need. Because of the poor efficacy of synthetic polymers, the use of bladder acellular matrix (BAM) has been proposed. Indeed when cellular components are removed from xenogenic or allogeneic bladders, the extracellular matrix scaffold thus obtained can be used alone or in combination with stem cells. In this study, we propose the use of BAM seeded with marrow-derived mesenchymal stem cells (MSCs) for bladder tissue engineering. We optimized a protocol for decellularization of bladder tissue from different species including rat, rabbit and swine. We demonstrate the use of non-ionic detergents followed by nuclease digestion results in efficient decellularization while preserving the extracellular matrix. When MSCs were seeded on acellular matrix scaffold, they remained viable and proliferative while adopting a cellular phenotype consistent with their microenvironment. Upon transplantation in rats after partial cystectomy, MSC-seeded BAM proved superior to unseeded BAM with animals recovering nearly 100% normal bladder capacity for up to six months. Histological analyses also demonstrated increased muscle regeneration.

Indexed as

AnimalsBone Marrow CellsCell DifferentiationCell ProliferationCell SurvivalFemaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationRabbitsRatsTissue EngineeringTissue ScaffoldsUrinary Bladder

Identifiers

PMID25437001
PMCPMC4249849
OpenAlexW2083109974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.